Pasquini et al. (32) employed a machine learning approach to forecast the methylation status of the MGMT promoter in glioblastoma patients using MRI, achieving an accuracy of 70.8% and an AUC value of 0.688. This evidence concerns the gene MGMT and glioblastoma.